| Record ID | marc_columbia/Columbia-extract-20221130-016.mrc:11248164:2613 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-016.mrc:11248164:2613?format=raw |
LEADER: 02613cam a2200337Mi 4500
001 7524824
005 20221201010220.0
008 090821s2009 nyua b 001 0 eng d
016 7 $a990954153$2GyFmDB
020 $a9780387895833 (hd.bd.)
020 $a0387895833 (hd.bd.)
029 0 $aOHX$bhar080163502
035 $a(OCoLC)ocn432990104
035 $a(OCoLC)432990104
035 $a(NNC)7524824
035 $a7524824
040 $aOHX$cOHX$dBWX$dOrLoB-B$dNNC-M
082 0 $a615.36
090 $aRM287$b.C45 2009
245 00 $aCell therapy :$bcGMP facilities and manufacturing /$cAdrian Gee, editor.
260 $aNew York :$bSpringer,$c2009.
300 $axx, 256 pages :$billustrations (some color) ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $gPt. I.$tRegulatory --$gCh. 1.$tRegulation of Cell Product Manufacturing and Delivery: A United States Perspective --$gCh. 2.$tThe Regulatory Situation for Academic Cell Therapy Facilities in Europe --$gCh. 3.$tA Regulatory System for Cell and Tissue Therapies: Proposed Approach in Australia --$gPt. II.$tGMP Facility Design --$gCh. 4.$tUniversity of Minnesota - Molecular and Cellular Therapeutics (MCT) --$gCh. 5.$tUniversity of Pittsburgh Cancer Institute - Hematopoietic Stem Cell Laboratory (HSC Lab)/ Immunological Monitoring and Cellular Products Laboratory (IMCPL) --$gCh. 6.$tBaylor College of Medicine - Center for Cell and Gene Therapy (CAGT) --$gCh. 7.$tDesign of a New GMP Facility - Lessons Learned --$gPt. III.$tProfessional Cell Therapy Standards --$gCh. 8.$tAABB Cell Therapy Standards --$gCh. 9.$tProfessional Standards for Cellular Therapies: Foundation for the Accreditation of Cellular Therapy (FACT) --$gPt. IV.$tFacility Operations --$gCh. 10.$tStandard Operating Procedures --$gCh. 11.$tStaffing, Training, and Competency --$gCh. 12.$tCleaning Procedures --$gCh. 13.$tEnvironmental Monitoring --$gCh. 14.$tSupply Management --$gCh. 15.$tFacility Equipment --$gCh. 16.$tQuality --$gCh. 17.$tProduct Manufacturing --$gCh. 18.$tProduct Review, Release, and Administration --$gCh. 19.$tUse of a Facility Master File to Facilitate Regulatory Submissions for Cell Therapy Products.
650 0 $aCyclic guanylic acid$xTherapeutic use.
650 0 $aCellular therapy.$0http://id.loc.gov/authorities/subjects/sh85021700
650 12 $aImmunotherapy, Adoptive.$0https://id.nlm.nih.gov/mesh/D016219
650 22 $aHematopoietic Stem Cells$xphysiology.$0https://id.nlm.nih.gov/mesh/D006412Q000502
852 00 $boff,hsl$hRM287$i.C45 2009